AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14975482 — intervention group
Group type: COMPARATOR
Intervention: Control (8.2 hours of sleep for 10 days)
Number of subjects: 20
Study 11312068 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (20 g/d)
Number of subjects: 0
Study 11312068 — intervention group
Group type: COMPARATOR
Intervention: Placebo (whey protein)
Number of subjects: 0
Study 9143867 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton 600 mg every 6 h for 10 days
Number of subjects: 16
Study 9143867 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg every 12 h for 7 days
Number of subjects: 16
Study 9143867 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of zileuton and terfenadine
Number of subjects: 16
Study 9143867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 7945979 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic responses during performance of an anticipation task
Number of subjects: 11
Study 7945979 — intervention group
Group type: EXPERIMENTAL
Intervention: Six task modalities
Number of subjects: 11
Study 7945979 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic variables
Number of subjects: 11
Study 3129596 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nutritional support (PNS) with 30 kcal/kg/day and 200 mg/kg/day of nitrogen for at least 7 days
Number of subjects: 100
Study 3129596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative nutritional support)
Number of subjects: 100
Study 3129596 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nutritional support (PNS) in malnourished patients
Number of subjects: 100
Study 3129596 — intervention group
Group type: COMPARATOR
Intervention: Control group (malnourished patients without PNS)
Number of subjects: 100
Study 3129596 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nutritional support (PNS) in malnourished patients undergoing gastrectomy
Number of subjects: 100
Study 3129596 — intervention group
Group type: COMPARATOR
Intervention: Control group (malnourished patients undergoing gastrectomy without PNS)
Number of subjects: 100
Study 3129596 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nutritional support (PNS)
Number of subjects: 100
Study 29693279 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially microgrooved healing abutments (n=15)
Number of subjects: 28
Study 29693279 — intervention group
Group type: COMPARATOR
Intervention: Machined healing abutments (n=13)
Number of subjects: 28
Study 28376151 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment plus aggressive local treatment by radiofrequency ablation ± resection
Number of subjects: 119
Study 28376151 — intervention group
Group type: COMPARATOR
Intervention: Systemic treatment alone
Number of subjects: 119
Study 26762075 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure monitoring in patients with arterial hypertension during acute gastrointestinal bleeding
Number of subjects: 45
Study 26762075 — intervention group
Group type: EXPERIMENTAL
Intervention: Holter monitoring in patients with arterial hypertension during acute gastrointestinal bleeding
Number of subjects: 45
Study 23606168 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 190
Study 23606168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 21990056 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical vibrating, 35 Hz, 1.7 mm (VG)
Number of subjects: 108
Study 21990056 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational vibrating 12.5 Hz, 12 mm (RG)
Number of subjects: 108
Study 21990056 — intervention group
Group type: COMPARATOR
Intervention: Low intensity gymnastic and relaxation program (Control Group)
Number of subjects: 108
Study 18472670 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abuse treatment for rural adolescents
Number of subjects: 404
Study 18472670 — intervention group
Group type: COMPARATOR
Intervention: Substance abuse treatment for urban adolescents
Number of subjects: 404
Study 18472670 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abuse treatment for both groups
Number of subjects: 404
Study 17006323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin microemulsion (CsA)
Number of subjects: 129
Study 17006323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 129
Study 17006323 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (CTL)
Number of subjects: 129
Study 12571666 — intervention group
Group type: EXPERIMENTAL
Intervention: fortified diet - usual diet plus 100 microg/day folic acid from fortified foods
Number of subjects: 135
Study 12571666 — intervention group
Group type: EXPERIMENTAL
Intervention: natural folate diet - usual diet plus 100 microg/day folate from natural sources
Number of subjects: 135
Study 12571666 — intervention group
Group type: COMPARATOR
Intervention: control - usual diet
Number of subjects: 135
Study 11138438 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention consisting of six 90-minute sessions focusing on media literacy and advocacy skills.
Number of subjects: 226
Study 11138438 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 226
Study 11138438 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 226
Study 9020555 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy in patients with various tumors (lung cancers, lymphomas, and others)
Number of subjects: 66
Study 9020555 — intervention group
Group type: EXPERIMENTAL
Intervention: Local radiotherapy in female patients with cervical or endometrial carcinoma
Number of subjects: 66
Study 1399993 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2
Number of subjects: 0
Study 1399993 — intervention group
Group type: EXPERIMENTAL
Intervention: PGF2 alpha
Number of subjects: 0
Study 1399993 — intervention group
Group type: COMPARATOR
Intervention: Control (citric acid)
Number of subjects: 0
Study 4044466 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibunazole 400 mg tablets administered alone
Number of subjects: 6
Study 4044466 — intervention group
Group type: COMPARATOR
Intervention: Vibunazole 400 mg tablets administered after 400 mg cimetidine
Number of subjects: 6
Study 4044466 — intervention group
Group type: COMPARATOR
Intervention: Vibunazole 400 mg tablets administered after 30 ml diluted hydrochloric acid
Number of subjects: 6
Study 31687165 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) group intervention
Number of subjects: 88
Study 31687165 — intervention group
Group type: COMPARATOR
Intervention: Behavioural Weight-Loss (BWL) intervention
Number of subjects: 88
Study 31687165 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ACT and BWL groups
Number of subjects: 88
Study 28962842 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse (no preparation)
Number of subjects: 48
Study 28962842 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch (no preparation)
Number of subjects: 48
Study 28962842 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse with dentin roughening (ER+RO)
Number of subjects: 48
Study 28962842 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch with dentin roughening (SE+RO)
Number of subjects: 48
Study 28962842 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study 27253174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin (0.5 μg kg(‐1) h(‐1)) for 5 days
Number of subjects: 40
Study 27253174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27253174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin
Number of subjects: 40
Study 25201815 — intervention group
Group type: EXPERIMENTAL
Intervention: cPMd modulation (1-Hz rTMS)
Number of subjects: 44
Study 25201815 — intervention group
Group type: EXPERIMENTAL
Intervention: cM1 modulation (1-Hz rTMS)
Number of subjects: 44
Study 25201815 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 44
Study 21383086 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week interruption of ART
Number of subjects: 0
Study 21383086 — intervention group
Group type: EXPERIMENTAL
Intervention: ART intensification
Number of subjects: 0
Study 21383086 — intervention group
Group type: COMPARATOR
Intervention: Standard ART
Number of subjects: 0
Study 21383086 — intervention group
Group type: COMPARATOR
Intervention: No interruption of ART
Number of subjects: 0
Study 20172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (target blood level, 3‐8 ng/mL)
Number of subjects: 22
Study 20172327 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (2.0‐2.5 mg/kg/d)
Number of subjects: 22
Study 20172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 22
Study 20172327 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 22
Study 20172327 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study 18308419 — intervention group
Group type: EXPERIMENTAL
Intervention: VNR 25mg/m² on day 1, 8 and 15 plus CDDP 100mg/m² on day 1 every 4 weeks
Number of subjects: 278
Study 18308419 — intervention group
Group type: COMPARATOR
Intervention: VNR 30 mg/m² on day 1 and 8 plus CDDP 80 mg/m² on day 1 every 3 weeks
Number of subjects: 278
Study 16095419 — intervention group
Group type: EXPERIMENTAL
Intervention: Group SC (n = 11) - climbed up and down stairs
Number of subjects: 32
Study 16095419 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ES (n = 11) - practiced electrostimulation
Number of subjects: 32
Study 16095419 — intervention group
Group type: EXPERIMENTAL
Intervention: Group SC + ES (n = 10) - superimposed climbing stairs and electrostimulation
Number of subjects: 32
Study 16095419 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 32
Study 11821466 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (RT) with five doses of 5 Gy
Number of subjects: 1530
Study 11821466 — intervention group
Group type: COMPARATOR
Intervention: TME surgery alone
Number of subjects: 1530
Study 11180567 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted scores derived from patients' responses using the EuroQol instrument's visual analogue scale.
Number of subjects: 649
Study 11180567 — intervention group
Group type: COMPARATOR
Intervention: Predicted scores derived from the general public's responses to the EuroQol instrument.
Number of subjects: 649
Study 9204057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg twice a day
Number of subjects: 201
Study 9204057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 600 mg twice a day
Number of subjects: 201
Study 9204057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 8516421 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light intervention
Number of subjects: 17
Study 8516421 — intervention group
Group type: COMPARATOR
Intervention: Control (no bright light)
Number of subjects: 17
Study 3089123 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% medium chain triglycerides (MCT)/50% long chain triglycerides (LCT) mixture
Number of subjects: 13
Study 3089123 — intervention group
Group type: COMPARATOR
Intervention: long chain triglyceride emulsion (LCT)
Number of subjects: 13
Study 28422539 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (NIT) 140 mL daily for 3 days
Number of subjects: 8
Study 28422539 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study 28422539 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (NIT)
Number of subjects: 8
Study 28531113 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 129
Study 28531113 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus Policaptil Gel Retard® (PGR)
Number of subjects: 129
Study 28531113 — intervention group
Group type: COMPARATOR
Intervention: Control group (LGI diet only)
Number of subjects: 129
Study 25965717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily
Number of subjects: 41
Study 25965717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 23260188 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including qualitative and quantitative assessment of barriers to alteplase use and additional support.
Number of subjects: 40823
Study 23260188 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40823
Study 21539743 — intervention group
Group type: EXPERIMENTAL
Intervention: CURB65-A risk class I (CURB65 score 0-1 and ProADM ≤0.75 nmol/l)
Number of subjects: 1359
Study 21539743 — intervention group
Group type: EXPERIMENTAL
Intervention: CURB65-A risk class II (CURB65 score 2 and ProADM ≤1.5 nmol/l or CURB classes 0-1 and ProADM levels between 0.75-1.5 nmol/L)
Number of subjects: 1359
Study 21539743 — intervention group
Group type: EXPERIMENTAL
Intervention: CURB65-A risk class III (all other patients)
Number of subjects: 1359
Study 21539743 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment for CURB65-A risk class I
Number of subjects: 1359
Study 21539743 — intervention group
Group type: EXPERIMENTAL
Intervention: Short hospitalization for CURB65-A risk class II
Number of subjects: 1359
Study 18456557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 145
Study 18456557 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ketogenic diet)
Number of subjects: 145
Study 16548938 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Contact group (5 proactive calls in addition to usual care)
Number of subjects: 1457
Study 16548938 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 1457
Study 16548938 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Contact group
Number of subjects: 1457
Study 16548938 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1457
Study 14605970 — intervention group
Group type: COMPARATOR
Intervention: Flexible multiple daily insulin (FMDI) regimen
Number of subjects: 44
Study 10722029 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced CT examination (Group A)
Number of subjects: 20
Study 10722029 — intervention group
Group type: COMPARATOR
Intervention: CT examination without contrast-enhanced medium (Group B)
Number of subjects: 20
Study 9364627 — intervention group
Group type: EXPERIMENTAL
Intervention: 50.4 Gy schedule (2 x 1.8 Gy/day to a total dose of 50.4 Gy)
Number of subjects: 62
Study 9364627 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Gy schedule (2 x 2.5 Gy/day to a total dose of 30 Gy)
Number of subjects: 62
Study 9364627 — intervention group
Group type: COMPARATOR
Intervention: Historical control group (1 daily fraction of 3 Gy up to 30 Gy)
Number of subjects: 62
Study 1542320 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg daily)
Number of subjects: 356
Study 1542320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study 30297018 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverage reduction intervention
Number of subjects: 146
Study 30297018 — intervention group
Group type: COMPARATOR
Intervention: Income-ineligible nonparticipants
Number of subjects: 146
Study 30297018 — intervention group
Group type: COMPARATOR
Intervention: SNAP participants
Number of subjects: 146
Study 25056532 — intervention group
Group type: COMPARATOR
Intervention: EPUFAs
Number of subjects: 0
Study 25056532 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 0
Study 25056532 — intervention group
Group type: COMPARATOR
Intervention: EPUFAs and Vitamin E
Number of subjects: 0
Study 25056532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25666957 — intervention group
Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 0
Study 25666957 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 0
Study 25666957 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 0
Study 25666957 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients and non-smokers
Number of subjects: 0
Study 23106176 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fractionation (2.0 Gy per day, total 68 Gy during 7 weeks)
Number of subjects: 712
Study 23106176 — intervention group
Group type: COMPARATOR
Intervention: Accelerated fractionation (1.1 + 2.0 Gy per day, total 68 Gy during 4.5 weeks)
Number of subjects: 712
Study 21129235 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (1.48 g EPA+DHA/d) for 12 weeks
Number of subjects: 113
Study 21129235 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 113
Study 18665697 — intervention group
Group type: EXPERIMENTAL
Intervention: IE/IVE/CR
Number of subjects: 118
Study 18665697 — intervention group
Group type: COMPARATOR
Intervention: IE
Number of subjects: 118
Study 18665697 — intervention group
Group type: COMPARATOR
Intervention: IVE
Number of subjects: 118
Study 18665697 — intervention group
Group type: COMPARATOR
Intervention: IE/IVE
Number of subjects: 118
Study 16391155 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-free, rapamycin-coated Yukon DES (rapamycin stent)
Number of subjects: 450
Study 16391155 — intervention group
Group type: COMPARATOR
Intervention: Polymer-based, paclitaxel-eluting Taxus stent (paclitaxel stent)
Number of subjects: 450
Study 12732857 — intervention group
Group type: EXPERIMENTAL
Intervention: Minute Ventilation Test (MVT)
Number of subjects: 42
Study 12732857 — intervention group
Group type: COMPARATOR
Intervention: Clinical Judgement
Number of subjects: 42
Study 12732857 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 10992830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.3 mg)
Number of subjects: 38
Study 10992830 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled i.v. morphine alone (control)
Number of subjects: 38
Study 8787884 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir 500 mg (normotensive)
Number of subjects: 29
Study 8787884 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir 1,000 mg (normotensive)
Number of subjects: 29
Study 8787884 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir 500 mg (hypertensive)
Number of subjects: 29
Study 8787884 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir (all groups)
Number of subjects: 29
Study 8787884 — intervention group
Group type: COMPARATOR
Intervention: Valaciclovir (elderly)
Number of subjects: 29
Study 1460154 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent methadone take-home privileges
Number of subjects: 53
Study 1460154 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent procedure
Number of subjects: 53
Study 1460154 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent procedure shifting to contingent procedure
Number of subjects: 53
Study 3883493 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin administered at 6 p.m. followed by cisplatin at 6 a.m.
Number of subjects: 31
Study 3883493 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin administered at 6 a.m. followed by cisplatin at 6 p.m.
Number of subjects: 31
Study 30857184 — intervention group
Group type: EXPERIMENTAL
Intervention: FT-NIR spectroscopy with partial least discriminant analysis (PLS-DA) model
Number of subjects: 100
Study 29719989 — intervention group
Group type: EXPERIMENTAL
Intervention: Abductive theory of method (ATOM)
Number of subjects: 0
Study 29719989 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trial (RCT)
Number of subjects: 0
Study 27258524 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1 μg/kg for 10 minutes, followed by continuous infusion at 0.5 μg/kg/h until 30 minutes before the end of surgery)
Number of subjects: 94
Study 27258524 — intervention group
Group type: COMPARATOR
Intervention: Saline (same volume as dexmedetomidine)
Number of subjects: 94
Study 25037677 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II diabetes mellitus group (DM)
Number of subjects: 0
Study 25037677 — intervention group
Group type: COMPARATOR
Intervention: Non-diabetes mellitus group (non-DM)
Number of subjects: 0
Study 25037677 — intervention group
Group type: EXPERIMENTAL
Intervention: EAT volume >120 cm(3)
Number of subjects: 0
Study 22664394 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite meal (protein rich food, carbohydrate rich food, and vegetable)
Number of subjects: 51
Study 22664394 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate meal (protein rich food and vegetable)
Number of subjects: 51
Study 22664394 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian meal (carbohydrate rich food and vegetable)
Number of subjects: 51
Study 22664394 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual foods presentation (stir-fry or stew)
Number of subjects: 51
Study 22664394 — intervention group
Group type: COMPARATOR
Intervention: Composite meal (stir-fry or stew)
Number of subjects: 51
Study 19845547 — intervention group
Group type: EXPERIMENTAL
Intervention: VR004 (apomorphine) 100-300 microg
Number of subjects: 600
Study 19845547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study 16523157 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolate aspherical IOL (TECNIS Z9000, AMO, USA)
Number of subjects: 20
Study 16523157 — intervention group
Group type: COMPARATOR
Intervention: Spherical IOL (911 CeeOn Edge, AMO, USA)
Number of subjects: 20
Study 15249568 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir DF
Number of subjects: 602
Study 15249568 — intervention group
Group type: COMPARATOR
Intervention: Stavudine
Number of subjects: 602
Study 11110739 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem solving treatment (n=128)
Number of subjects: 452
Study 11110739 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention of depression (n=108)
Number of subjects: 452
Study 11110739 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=189)
Number of subjects: 452
Study 9314468 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-HAV detection in IDUs
Number of subjects: 900
Study 9314468 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-HAV detection in homosexual males
Number of subjects: 900